The moment that IMA issues a press release saying they are going go to trials with a test involving recaf I will be the biggest cheerleader this stock has ever seen. Too many times, and for too long, have press releases such as this been put out, only to see hopeful investors buy into this company no where near the implied marketization of a test.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.